A Pilot Study of Oraxol in Subjects With Cutaneous Angiosarcoma
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2019
Price : $35 *
At a glance
- Drugs Encequidar+paclitaxel-Athenex (Primary)
- Indications Haemangiosarcoma; Skin cancer
- Focus Therapeutic Use
- Sponsors Athenex
- 15 Oct 2019 Planned number of patients changed from 14 to 25.
- 03 May 2019 Results from the part 1 of the study were presented in an Athenex media release.
- 03 May 2019 According to an Athenex media release, till date 10 patients have been enrolled in this study. Based on the preliminary data, the study has met the criteria required to proceed to full enrollment.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History